Top Markets
#1 Cortex Cortex +32.75%
#2 Akedo Akedo +13.64%
#3 MarsCoin MarsCoin +13.33%
#4 龙虾 (Lobster) 龙虾 (Lobster) +12.39%
#5 Pons Pons +11.05%
#6 The Black Bull The Black Bull +10.44%
#7 Everything Everything +10.25%
#8 EXOD EXOD +9.04%
#9 Peapods Finance Peapods Finance +7.77%
#10 Official Trump Official Trump +7.45%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rangering i aksjer #6887
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Aksjekurs
$14.30
Sist synkronisert: 2023-06-29
Markedsverdi
$1.81B
Endring (1 dag)
-2.81%
Endring (1 år)
0.00%
Land
CA
Handel BELLUS Health Inc. (BLU)

Kategori

Healthcare
Utbytteavkastning for BELLUS Health Inc. (BLU)
BELLUS Health Inc. (aksjesymbol: BLU) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for BELLUS Health Inc. (BLU) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH